Cargando…

Retinoic Acid Induces an IFN-Driven Inflammatory Tumour Microenvironment, Sensitizing to Immune Checkpoint Therapy

With immune checkpoint therapy (ICT) having reshaped the treatment of many cancers, the next frontier is to identify and develop novel combination therapies to improve efficacy. Previously, we and others identified beneficial immunological effects of the vitamin A derivative tretinoin on anti-tumour...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tilsed, Caitlin M., Casey, Thomas H., de Jong, Emma, Bosco, Anthony, Zemek, Rachael M., Salmons, Joanne, Wan, Graeme, Millward, Michael J., Nowak, Anna K., Lake, Richard A., Lesterhuis, Willem Joost
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988133/ https://www.ncbi.nlm.nih.gov/pubmed/35402250 http://dx.doi.org/10.3389/fonc.2022.849793

Ejemplares similares

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
por: Zemek, Rachael M., et al.
Publicado: (2020)

Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice
por: Zemek, Rachael M., et al.
Publicado: (2022)

Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action
por: Tilsed, Caitlin M., et al.
Publicado: (2022)

Tumor Infiltrating Effector Memory Antigen-Specific CD8(+) T Cells Predict Response to Immune Checkpoint Therapy
por: Principe, Nicola, et al.
Publicado: (2020)

Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations
por: Principe, Nicola, et al.
Publicado: (2022)

Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment
por: Aston, Wayne J., et al.
Publicado: (2019)

Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses
por: Kidman, Joel, et al.
Publicado: (2020)

Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-Tumor Immunity
por: Lesterhuis, W. Joost, et al.
Publicado: (2013)

Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma
por: Orozco Morales, M. Lizeth, et al.
Publicado: (2023)

Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations
por: Lesterhuis, W. Joost, et al.
Publicado: (2015)

Malignant Pleural Effusions—A Window Into Local Anti-Tumor T Cell Immunity?
por: Principe, Nicola, et al.
Publicado: (2021)

A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice
por: Aston, Wayne J., et al.
Publicado: (2017)

Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
por: Chee, Jonathan, et al.
Publicado: (2018)

Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression
por: Armitage, Jesse D., et al.
Publicado: (2021)

Unravelling Tumour Microenvironment in Melanoma at Single-Cell Level and Challenges to Checkpoint Immunotherapy
por: Bai, Xinyu, et al.
Publicado: (2022)

Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components
por: Hsu, Sheng-Kai, et al.
Publicado: (2022)

A retinoic acid–dependent checkpoint in the development of CD4(+) T cell–mediated immunity
por: Pino-Lagos, Karina, et al.
Publicado: (2011)

Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer
por: Al‐Badran, Sara SF, et al.
Publicado: (2020)

A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment
por: Wei, Cheng-Hsin, et al.
Publicado: (2023)

Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint
por: Verma, Navin Kumar, et al.
Publicado: (2022)

Restoration of defective cross-presentation in tumors by gemcitabine
por: McDonnell, Alison M, et al.
Publicado: (2015)

Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
por: Rozali, Esdy N., et al.
Publicado: (2012)

PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective
por: Orozco Morales, M. Lizeth, et al.
Publicado: (2021)

Directing the Future Breakthroughs in Immunotherapy: The Importance of a Holistic Approach to the Tumour Microenvironment
por: Newnes, Hannah V., et al.
Publicado: (2021)

Tamoxifen Modulates the Immune Landscape of the Tumour Microenvironment: The Paired Siglec-5/14 Checkpoint in Anti-Tumour Immunity in an In Vitro Model of Breast Cancer
por: Wielgat, Przemyslaw, et al.
Publicado: (2023)

Adrenomedullin and tumour microenvironment
por: Larráyoz, Ignacio M, et al.
Publicado: (2014)

The hypoxic tumour microenvironment
por: Petrova, Varvara, et al.
Publicado: (2018)

Neuroendocrine tumours and their microenvironment
por: de Hosson, Lotte D., et al.
Publicado: (2020)

Beyond the tumour microenvironment
por: Laplane, Lucie, et al.
Publicado: (2019)

The role of IFN-γ-signalling in response to immune checkpoint blockade therapy
por: Wong, Chun Wai, et al.
Publicado: (2023)

The role of the tumour microenvironment in the angiogenesis of pituitary tumours
por: Marques, Pedro, et al.
Publicado: (2020)

The Role of CDK5 in Tumours and Tumour Microenvironments
por: Do, Phuong Anh, et al.
Publicado: (2020)

The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer
por: van Wyk, Hester C, et al.
Publicado: (2016)

Circular RNAs in the tumour microenvironment
por: Ma, Zhonghua, et al.
Publicado: (2020)

Metabolism in the Tumour-Bone Microenvironment
por: Whitburn, Jessica, et al.
Publicado: (2021)

Cellular senescence and the tumour microenvironment
por: Takasugi, Masaki, et al.
Publicado: (2022)

Tumour microenvironment in pheochromocytoma and paraganglioma
por: Martinelli, Serena, et al.
Publicado: (2023)

The regulation of immune checkpoints by the hypoxic tumor microenvironment
por: Hu, Min, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Human Glioma Microenvironment
por: Ghouzlani, Amina, et al.
Publicado: (2021)

Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
por: Marques, Pedro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4ukkmsooqdr6i69qmgpik2gpe9